4-(4-(4-(4-(((3R,5R)-5-(2,4-DIFLUOROPHENYL)-5-(1,2,4-TRIAZOL-1-YLMETHYL)OXOLAN-3-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)PHENYL)-2-((2S,3S)-2-HYDROXYHEXAN-3-YL)-1,2,4-TRIAZOL-3-ONE
UNII L7X6Q4H88M
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(4-(4-(4-(((3r,5r)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((2s,3s)-2-hydroxyhexan-3-yl)-1,2,4-triazol-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L7X6Q4H88M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C38H44F2N8O4 PJSOSOTUOAGKOT-XQPVTFFNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(4-(4-(4-(((3r,5r)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((2s,3s)-2-hydroxyhexan-3-yl)-1,2,4-triazol-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.